凱因科技(688687.SH):多名股東擬合計減持不超過3%股份
格隆匯4月21日丨凱因科技(688687.SH)公佈,公司於近日收到富山灣、富寧灣、卓尚石、卓尚灣出具的《股份減持計劃告知函》,現將減持計劃具體情況公告如下:富山灣、富寧灣、卓尚石、卓尚灣因其持有人自身資金需求,擬通過集中競價及大宗交易的方式減持其所持有的公司股份合計不超過5,128,000股,即不超過公司總股本的3.00%。自本減持計劃公告之日起15個交易日後的3個月內(2025年5月16日至2025年8月15日)實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.